148 related articles for article (PubMed ID: 34742012)
1. Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: Ascribe possibilities of new antitumor strategies.
Bai X; Ali A; Wang N; Liu Z; Lv Z; Zhang Z; Zhao X; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2022 Jan; 227():113920. PubMed ID: 34742012
[TBL] [Abstract][Full Text] [Related]
2. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
[TBL] [Abstract][Full Text] [Related]
3. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
[TBL] [Abstract][Full Text] [Related]
4. Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.
Wang N; Ali A; Liu Z; Chi H; Lv Z; Zhao X; Zhang Z; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2023 Oct; 258():115536. PubMed ID: 37295260
[TBL] [Abstract][Full Text] [Related]
5. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of dimethylpyridine-platinum complexes with potent antiproliferative activity.
Czarnomysy R; Bielawski K; Muszynska A; Bielawska A; Gornowicz A
J Enzyme Inhib Med Chem; 2016; 31(sup3):150-165. PubMed ID: 27488500
[TBL] [Abstract][Full Text] [Related]
7. Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.
Scaffidi-Domianello YY; Legin AA; Jakupec MA; Roller A; Kukushkin VY; Galanski MS; Keppler BK
Inorg Chem; 2012 Jul; 51(13):7153-63. PubMed ID: 22691006
[TBL] [Abstract][Full Text] [Related]
8. Syntheses, crystal structures, and biological evaluations of new dinuclear platinum(ii) complexes with 1,2,4-triazole derivatives as bridging ligands.
Wang J; Li X; Yuan C; Su F; Wu YB; Lu L; Zhu M; Xing S; Fu X
Dalton Trans; 2021 Apr; 50(13):4527-4538. PubMed ID: 33725030
[TBL] [Abstract][Full Text] [Related]
9. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways.
Bai X; Ali A; Lv Z; Wang N; Zhao X; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2021 Nov; 224():113689. PubMed ID: 34293698
[TBL] [Abstract][Full Text] [Related]
10. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic Acid.
Zmejkovski BB; Pantelić N; Filipović L; Aranđelović S; Radulović S; Sabo TJ; Kaluđerović GN
Anticancer Agents Med Chem; 2017; 17(8):1136-1143. PubMed ID: 27928952
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes.
Savić A; Filipović L; Aranđelović S; Dojčinović B; Radulović S; Sabo TJ; Grgurić-Šipka S
Eur J Med Chem; 2014 Jul; 82():372-84. PubMed ID: 24927057
[TBL] [Abstract][Full Text] [Related]
13. Anticancer Activity Assessment and DNA Binding Properties of Two Binuclear Platinum (II) Complexes using Spectroscopic and Molecular Simulation Approaches.
Alavianmehr MM; Ashrafi A; Yousefi R; Haghighi MG; Abolmaali SS; Moosavi-Movahedi AA; Rad MNS
Anticancer Agents Med Chem; 2020; 20(17):2066-2073. PubMed ID: 32628598
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anticancer activity of novel platinum(II) bis(thiosemicarbazone) complex against breast cancer.
Radomska D; Szewczyk-Roszczenko OK; Marciniec K; Książek M; Kusz J; Roszczenko P; Szymanowska A; Radomski D; Bielawski K; Czarnomysy R
Bioorg Chem; 2024 Jul; 148():107486. PubMed ID: 38788367
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of two platinum(II) complexes with 2-methyl-8-quinolinol derivatives as ligands and study of their antitumor activities.
Qin QP; Wang SL; Tan MX; Liu YC; Meng T; Zou BQ; Liang H
Eur J Med Chem; 2019 Jan; 161():334-342. PubMed ID: 30384040
[TBL] [Abstract][Full Text] [Related]
16. Targeting RNA polymerase I transcription machinery in cancer cells by a novel monofunctional platinum-based agent.
Zhang ZL; Zhao CL; Chen Q; Xu K; Qiao X; Xu JY
Eur J Med Chem; 2018 Jul; 155():434-444. PubMed ID: 29908438
[TBL] [Abstract][Full Text] [Related]
17. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
[TBL] [Abstract][Full Text] [Related]
18. ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway.
Rahman FU; Ali A; Duong HQ; Khan IU; Bhatti MZ; Li ZT; Wang H; Zhang DW
Eur J Med Chem; 2019 Feb; 164():546-561. PubMed ID: 30622026
[TBL] [Abstract][Full Text] [Related]
19. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
[TBL] [Abstract][Full Text] [Related]
20. Photocytotoxic cancer cell-targeting platinum(ii) complexes of glucose-appended curcumin and biotinylated 1,10-phenanthroline.
Upadhyay A; Gautam S; Ramu V; Kondaiah P; Chakravarty AR
Dalton Trans; 2019 Dec; 48(47):17556-17565. PubMed ID: 31748772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
